• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Lexicon Pharmaceuticals Inc

+ Add to Watchlist

LXRX:US

1.6300 USD 0.0800 5.16%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Lexicon Pharmaceuticals Inc (LXRX)

Open: 1.5600 Day's Range: 1.5000 - 1.6378 Volume: 1,410,431
Previous Close: 1.5500 52wk Range: 1.3850 - 3.1800 1-Yr Rtn: -25.57%

Stock Chart for LXRX

No chart data available.
  • LXRX:US 1.6300
  • 1D
  • 1M
  • 1Y
1.5500
Interactive LXRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LXRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2000
Est. EPS (USD) (12/2014) -0.1890
Est. PEG Ratio -
Market Cap (M USD) 837.48
Shares Outstanding (M) 513.79
30 Day Average Volume 1,588,039
Price/Book (mrq) 4.9192
Price/Sale (ttm) 376.5372
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LXRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LXRX

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches treatments for diabetes and obesity, cardiovascular disease, psychiatric and neurological disorders, cancer, immune system disorders, and ophthalmic disease.

Arthur T SandsPresident/CEO/Co-FounderJeffrey L WadeExec VP:Corporate Dev/CFO
Pablo LapuertaExec VP:Clinical DevBrian P ZambrowiczExec VP/Chief Scientific Ofcr
More Company Profile & Key Executives for LXRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil